BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12084470)

  • 21. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
    McGuigan C; Pathirana RN; Migliore M; Adak R; Luoni G; Jones AT; Díez-Torrubia A; Camarasa MJ; Velázquez S; Henson G; Verbeken E; Sienaert R; Naesens L; Snoeck R; Andrei G; Balzarini J
    J Antimicrob Chemother; 2007 Dec; 60(6):1316-30. PubMed ID: 17956908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?
    De Clercq E
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain.
    McGuigan C; Barucki H; Carangio A; Blewett S; Andrei G; Snoeck R; De Clercq E; Balzarini J; Erichsen JT
    J Med Chem; 2000 Dec; 43(26):4993-7. PubMed ID: 11150169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro.
    Shigeta S; Mori S; Kira T; Takahashi K; Kodama E; Konno K; Nagata T; Kato H; Wakayama T; Koike N; Saneyoshi M
    Antivir Chem Chemother; 1999 Jul; 10(4):195-209. PubMed ID: 10480738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine.
    Russ P; Schelling P; Scapozza L; Folkers G; Clercq ED; Marquez VE
    J Med Chem; 2003 Nov; 46(23):5045-54. PubMed ID: 14584954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core.
    Robins MJ; Nowak I; Rajwanshi VK; Miranda K; Cannon JF; Peterson MA; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2007 Aug; 50(16):3897-905. PubMed ID: 17622128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.
    McGuigan C; Derudas M; Quintiliani M; Andrei G; Snoeck R; Henson G; Balzarini J
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6264-7. PubMed ID: 19833513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
    Yokota T; Konno K; Shigeta S; De Clercq E
    Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
    Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
    J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.
    Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C
    Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antiviral evaluation of some 3'-fluoro bicyclic nucleoside analogues.
    McGuigan C; Carangio A; Snoeck R; Andrei G; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):1-5. PubMed ID: 15043132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
    Snoeck R; Andrei G; De Clercq E
    Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E; Descamps J; Ogata M; Shigeta S
    Antimicrob Agents Chemother; 1982 Jan; 21(1):33-8. PubMed ID: 6282207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
    Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
    J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor.
    Musella S; di Sarno V; Ciaglia T; Sala M; Spensiero A; Scala MC; Ostacolo C; Andrei G; Balzarini J; Snoeck R; Novellino E; Campiglia P; Bertamino A; Gomez-Monterrey IM
    Eur J Med Chem; 2016 Nov; 124():773-781. PubMed ID: 27639368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy.
    Pertusati F; Serafini S; Albadry N; Snoeck R; Andrei G
    Antiviral Res; 2017 Jul; 143():262-268. PubMed ID: 28454912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains.
    Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C
    J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.